secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0001193125-22-095136
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex grants stock options and 7% salary increases to top executives
-----------------------------------------------------------------------

- CEO Maurice Zauderer receives options for 28,000 shares at $1.29, vesting over 4 years.
- CSO Ernest Smith gets options for 20,000 shares; CFO Scott Royer gets 16,000 shares at same price.
- Base salaries raised 7%: Zauderer to $406,600, Smith to $287,981, Royer to $262,223.
- Options granted under 2018 Omnibus Incentive Plan, expire 10 years from grant date April 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522095136/0001193125-22-095136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522095136/d325737d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-095136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer